|
1
|
Caletti MG, Balestracci A and Di Pinto D:
Pre- and post-treatment urinary tract findings in children with
nephrogenic diabetes insipidus. Pediatr Nephrol. 29:487–490.
2014.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Bichet DG: Treatment of nephrogenic
diabetes insipidus. UpToDate. https://www.uptodate.com/contents/treatment-of-nephrogenic-diabetes-insipidus,
2017. Accessed June 14, 2019.
|
|
3
|
Moeller HB, Rittig S and Fenton RA:
Nephrogenic diabetes insipidus: Essential insights into the
molecular background and potential therapies for treatment. Endocr
Rev. 34:278–301. 2013.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Mishra G and Chandrashekhar SR: Management
of diabetes insipidus in children. Indian J Endocrinol Metab. 15
(Suppl 3):S180–S187. 2011.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Ranieri M, Di Mise A, Tamma G and Valenti
G: Vasopressin-aquaporin-2 pathway: Recent advances in
understanding water balance disorders. F1000Res.
8(F1000)2019.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Dabrowski E, Kadakia R and Zimmerman D:
Diabetes insipidus in infants and children. Best Pract Res Clin
Endocrinol Metab. 30:317–328. 2016.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Milano S, Carmosino M, Gerbino A, Svelto M
and Procino G: Hereditary nephrogenic diabetes insipidus:
Pathophysiology and possible treatment. An update. Int J Mol Sci.
18(2385)2017.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Sharma S, Ashton E, Iancu D, Arthus MF,
Hayes W, Van't Hoff W, Kleta R, Bichet DG and Bockenhauer D:
Long-term outcome in inherited nephrogenic diabetes insipidus. Clin
Kidney J. 12:180–187. 2018.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Birnbaumer M, Seibold A, Gilbert S, Ishido
M, Barberis C, Antaramian A, Brabet P and Rosenthal W: Molecular
cloning of the receptor for human antidiuretic hormone. Nature.
357:333–335. 1992.PubMed/NCBI View
Article : Google Scholar
|
|
10
|
van den Ouweland AM, Dreesen JC, Verdijk
M, Knoers NV, Monnens LA, Rocchi M and van Oost BA: Mutations in
the vasopressin type 2 receptor gene (AVPR2) associated with
nephrogenic diabetes insipidus. Nat Genet. 2:99–102.
1992.PubMed/NCBI View Article : Google Scholar
|
|
11
|
The Human Gene Mutation Database
(HGMD®). http://www.hgmd.cf.ac.uk/ac/gene.php. Accessed
September, 2020.
|
|
12
|
He J and Yang B: Aquaporins in renal
diseases. Int J Mol Sci. 20(366)2019.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Bichet DG: Clinical manifestations and
causes of nephrogenic diabetes insipidus. UpToDat. https://www.uptodate.com/contents/clinical-manifestations-and-causes-of-nephrogenic-diabetes-insipidus,
2018. Accessed June 14, 2019.
|
|
14
|
Sands JM: Water, water everywhere: A new
cause and a new treatment for nephrogenic diabetes insipidus. J Am
Soc Nephrol. 27:1872–1874. 2016.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Bockenhauer D and Bichet DG: Urinary
concentration: Different ways to open and close the tap. Pediatr
Nephrol. 29:1297–1303. 2014.PubMed/NCBI View Article : Google Scholar
|
|
16
|
D'Alessandri-Silva C, Carpenter M, Ayoob
R, Barcia J, Chishi A, Constantinescu A, Dell KM, Goodwin J,
Hashmat S, Iragorri S, et al: Diagnosis, treatment, and outcomes in
children with congenital nephrogenic diabetes insipidus: A
pediatric nephrology research consortium study. Front Pediatr.
7(550)2020.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Lejarraga H, Caletti MG, Caino S and
Jiménez A: Long-term growth of children with nephrogenic diabetes
insipidus. Pediatr Nephro. l23:2007–2012. 2008.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Ando F and Uchida S: Activation of AQP2
water channels without vasopressin: Therapeutic strategies for
congenital nephrogenic diabetes insipidus. Clin Exp Nephrol.
22:501–507. 2018.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Wesche D, Deen PM and Knoers NV:
Congenital nephrogenic diabetes insipidus: The current state of
affairs. Pediatr Nephrol. 27:2183–2204. 2012.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Di Iorgi N, Napoli F, Allegri AE, Olivieri
I, Bertelli E, Gallizia A, Rossi A and Maghnie M: Diabetes
Insipidus diagnosis and management. Horm Res Pediat. 77:69–84.
2012.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Saborio P, Tipton GA and Chan JC: Diabetes
insipidus. Pediatr Rev. 21:122–129. 2000.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Priya G, Kalra S, Dasgupta A and Grewal E:
Diabetes insipidus: A pragmatic approach to management. Cureus.
13(e12498)2021.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Weiner A and Vuguin P: Diabetes insipidus.
Pediatr Rev. 41:96–99. 2020.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Bichet DG: Evaluation of patients with
polyuria. UpToDate. https://www.uptodate.com/contents/evaluation-of-patients-with-polyuria,
2019. Accessed June 14, 2019.
|
|
25
|
Sreedharan R and Avner ED: Nephrogenic
diabetes insipidus. In: Kliegman RM, Stanton BF, St Geme JW, Schor
NF (eds). Nelson Textbook of Pediatrics. 20th edition. Elsevier,
pp2532-2533, 2016.
|
|
26
|
Procino G, Milano S, Carmosino M, Gerbino
A, Bonfrate L, Portincasa P and Svelto M: Hereditary nephrogenic
diabetes insipidus: Molecular basis of the defect and potential
novel strategies for treatment. J Genet Syndr Gene Ther.
5(225)2014.
|
|
27
|
Bănescu C: Do we really need genetic tests
in current practice? Rev Romana Med Lab. 27:9–14. 2019.
|
|
28
|
Duicu C: Genetic testing in pediatrics-a
narrative essay of challenges and possibilities in Romania. Rev
Romana Med Lab. 27:355–359. 2019.
|
|
29
|
Bockenhauer D and Bichet DG:
Pathophysiology, diagnosis and management of nephrogenic diabetes
insipidus. Nat Rev Nephrol. 11:576–588. 2015.PubMed/NCBI View Article : Google Scholar
|
|
30
|
Abraham MB, Rao S, Price G and Choong CS:
Efficacy of hydrochlorothiazide and low renal solute feed in
neonatal central diabetes insipidus with transition to oral
desmopressin in early infancy. Int J Pediatr Endocrinol.
2014(11)2014.PubMed/NCBI View Article : Google Scholar
|
|
31
|
Ziegler EE and Fomon SJ: Potential renal
solute load of infant formulas. J Nutr. 119 (12 Suppl):S1785–S1788.
1989.PubMed/NCBI View Article : Google Scholar
|
|
32
|
Nevin-Folino N and Miller M: Enteral
nutrition. In: Samour PQ, King K (eds). Handbook of Pediatric
Nutrition. 3rd edition. Jones and Bartlett Publishers, pp499-524,
2005.
|
|
33
|
Bech AP, Wetzels JFM and Nijenhuis T:
Effects of sildenafil, metformin, and simvastatin on
ADH-independent urine concentration in healthy volunteers. Physiol
Rep. 6(e13665)2018.PubMed/NCBI View Article : Google Scholar
|
|
34
|
Assadi F and Sharbaf FG: Sildenafil for
the treatment of congenital nephrogenic diabetes insipidus. Am J
Nephrol. 42:65–69. 2015.PubMed/NCBI View Article : Google Scholar
|
|
35
|
Schernthaner-Reiter MH, Stratakis CA and
Luger A: Genetics of diabetes insipidus. Endocrinol Metab Clin
North Am. 46:305–334. 2017.PubMed/NCBI View Article : Google Scholar
|
|
36
|
Los EL, Deen PM and Robben JH: Potential
of nonpeptide (ant)agonists to rescue vasopressin V2 receptor
mutants for the treatment of X-linked nephrogenic diabetes
insipidus. J Neuroendocrinol. 22:393–399. 2010.PubMed/NCBI View Article : Google Scholar
|
|
37
|
Tuncdemir BE, Mergen H and Saglar Ozer E:
Evaluation of pharmacochaperone-mediated rescue of mutant V2
receptor proteins. Eur J Pharmacol. 865(172803)2019.PubMed/NCBI View Article : Google Scholar
|
|
38
|
Prosperi F, Suzumoto Y, Marzuillo P,
Costanzo V, Jelen S, Iervolino A, Guarino S, La Manna A, Miraglia
Del Giudice E, Perna AF, et al: Characterization of five novel
vasopressin V2 receptor mutants causing nephrogenic diabetes
insipidus reveals a role of tolvaptan for M272R-V2R mutation. Sci
Rep. 10(16383)2020.PubMed/NCBI View Article : Google Scholar
|
